Tag: VTE
Longer fasting before venography appears to impact stent size selection, new...
During the 2024 American Venous Forum (AVF) annual meeting in Tampa, Florida (March 3–6), Kurt S. Schultz, MD, a general surgery resident at the...
Tackling DVT head on: Single-session, wall-to-wall thrombus removal with the ClotTriever...
This advertorial is sponsored by Inari Medical.
Several years ago, when Nicolas Mouawad, MD, division chief of vascular surgery at McLaren Health in Bay City,...
The pulmonary arterial tree—it is time we branch out
Nicolas Mouawad, MD, chief of vascular surgery at McLaren Health System in Bay City, Michigan, urges vascular surgeons to “get out of their comfort...
NESVS 2023: Novel IVC filter retrieval device slashes procedural time and...
An inferior vena cava (IVC) filter retrieval device dubbed the next-generation in removal of the venous thromboembolism-fighting tools could substantially cut procedural times and...
Behind the procedure: Removing in-stent thrombosis with the RevCore Thrombectomy Catheter
This advertorial is sponsored by Inari Medical.
For patients with in-stent thrombosis (IST), one of the most critical unmet needs has been an effective method...
Child-bearing age ‘should not be a contraindication to venous stenting’
In a recently published study, dedicated venous stents performed well through pregnancy and postpartum, and a protocol including the use of low-dose antiplatelets in...
The top 10 most popular Vascular Specialist stories of July 2023
In the previous month, Vascular Specialist delivered a range of leading commentary from the Society for Vascular Surgery (SVS) in response to the New...
Study finds similar rates of VTE in both flying and non-flying...
Uncertainty underlying the magnitude of risk posed by long distance air travel in venous thromboembolism (VTE) patients has created the need for a deeper,...
Risk of cancer-related VTE recurrence ‘significantly lower’ using NOACs compared with...
Delivering results and recommendations from a systematic review and meta-analysis of novel oral anticoagulants (NOACs) versus low molecular weight heparin (LMWH) in the prevention...
Risk assessment models “no better than coin toss” for predicting bleeding...
A study of two risk assessment models (RAMs) for predicting the bleeding risk in patients considered for pharmacologic prophylaxis to prevent venous thromboembolism (VTE)...
The essential ‘need’ for vascular surgeons in pulmonary embolism treatment paradigm
The specter of pulmonary embolism (PE) as a common and lethal disease process—with mortality of massive PE static at about 50% for decades while...
AVF 2023: FLASH registry suggests ‘favorable safety and effectiveness profile’ in...
Among 61 high-risk pulmonary embolism (PE) patients followed through to the 30-day visit in the U.S. cohort of the FLASH registry, no mortalities were...
New study demonstrates IVC filters ‘safe and effective’ in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Abre stent data show ‘struggle to maintain patency’ among post-thrombotic syndrome...
The Abre venous stent demonstrated three-year primary patency rates of 97.1%, 76.5% and 70.4% respectively for non-thrombotic iliac vein lesion (NIVL), acute deep vein...
FLASH results demonstrate ‘excellent safety profile’ of the FlowTriever system in...
Results of the FLASH registry demonstrate the “excellent safety profile” of the FlowTriever system (Inari Medical) in 800 real-world patients.
This is according to Catalin...
Experts establish international standard set of outcome measures for patients with...
The International Consortium for Health Outcomes Measurement (ICHOM) venous thromboembolism (VTE) working group has developed a standard set of outcome measures for patients with...
Key differences in presentation, outcomes for distal versus proximal DVT uncovered
A new study highlights key differences in clinical features and comorbidities, as well as short-term and also long-term outcomes for patients with distal deep...
Compression duration affects pain during superficial venous intervention, study finds
Postprocedural compression of one to two weeks after superficial venous incompetence (SVI) treatment is associated with reduced pain compared with a shorter duration. This...
CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in...
This advertorial is sponsored by ACHL.
For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for...
Strength in numbers: Global VASCC COVID-19 project helps identify framework to...
When Robert Cuff, MD, and Max Wohlauer, MD, first launched the Vascular Surgery COVID-19 Collaborative (VASCC) back in the spring of 2020, the pandemic...
The year in COVID: VAM to feature 10 talks probing pandemic-related...
After nearly 18 months of life dominated by a worldwide pandemic—one that canceled the 2020 Vascular Annual Meeting (VAM)—VAM 2021 highlights several aspects of...
Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical
Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company's thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared...
Adjunctive compression to standard prophylaxis for postoperative VTE shows benefit in...
Among patients with a Caprini score of ≥11 who received standard prophylaxis for venous thromboembolism (VTE), adjunctive intermittent pneumatic compression (IPC) resulted in a significantly...
Venous2021 kicks off Wednesday, March 17
The American Venous Forum (AVF) will hold its 33rd annual meeting, Venous2021, in a virtual format from March 17–20.
The conference features scientific sessions covering...
AHA, ISTH release joint statement on future VTE research priorities
The American Heart Association (AHA) and the International Society on Thrombosis and Haemostasis (ISTH) issued a joint scientific statement July 8 outlining research priorities...
AHA issues call to action to prevent VTE in hospitalised patients
Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the U.S. and worldwide. A new policy statement from the American Heart...